Introduction
Semaglutide 0.25 mg injection is a novel formulation, used in weight loss and weight management when treating obese or overweight adults. It is an injectable solution produced by Novo Nordisk India, and administered via the injection pen known as Wegovy FlexTouch 0.25 mg that is self-administered by the user and through which the drug is injected into the body once a week. It is normally combined with a low-calorie diet and exercise so that a patient can have a healthier body mass and an improved state of metabolism.
What is Semaglutide 0.25 mg FlexTouch Pen?
Semaglutide 0.25 mg FlexTouch pen is a pre-filled, disposable injection pen, which is injected once a week. It contains semaglutide, a GLP-1 receptor agonist that mimics an endogenous hormone that controls insulin secretion and appetite. The dosing is closely targeted by this pen, and the patient can easily, comfortably, and accurately administer it to themselves. Semaglutide is known to slow gastric emptying and reduce brain hunger signals in order to promote a decrease in calorie intake and weight loss. The new design is innovative, which encourages compliance, an element that renders weight management effective.
Who Should Use Semaglutide 0.25 mg Pen?
Semaglutide 0.25 mg weight loss is targeted at adult patients with a body mass index (BMI) of 30 or higher (obese) or a BMI of 27 or higher with one or more weight-associated conditions, including type 2 diabetes, high blood pressure, or dyslipidemia.
Patients must be advised to adopt better diets and ways of life.
It must not be utilised in persons with a personal or family history of medullary thyroid.
Carcinoma, multiple endocrine neoplasia type 2, or pancreatitis in the past.
Should not be used without a medical recommendation by breastfeeding or pregnant women.
How to Take Semaglutide 0.25 mg
Take the Semaglutide FlexTouch pen, injecting (subcutaneously) either into the thigh, abdomen, or upper arm, rotating the injection site each time. The same day each week should be maintained for each dose. Only use needles and techniques as instructed by healthcare providers. Never share the pen between people, and avoid combining with other injectable medicines.
Benefits of Semaglutide 0.25 mg Pen
- Offers significant, sustainable weight loss
- Decreases appetite and hunger.
- Reduces blood pressure and waist circumference and enhances blood sugar control.
- Increases body strength and fitness.
- User-friendly FlexTouch pen for quick self-injection
- Proven effectiveness in a variety of patients with and without diabetes. <